Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Rakovina Therapeutics Inc. has successfully closed an oversubscribed $3 million private placement, which will accelerate the development of its cutting-edge cancer therapies. The company also announced a partnership with Fairfax Partners Inc. to enhance its market presence and expand its investor base through a comprehensive investor relations program.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.